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Abstract
Purpose—Treatment for rectal and anal cancer (RACa) can result in persistent bowel and
gastrointestinal (GI) dysfunction. Body image problems may develop over time and exacerbate
symptom-related distress. RACa survivors are an understudied group, however, and factors
contributing to post-treatment well-being are not well understood. This study examined whether
poorer body image explained the relation between symptom severity and psychological distress.
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Methods—Participants (N=70) completed the baseline assessment of a sexual health intervention
study. Bootstrap methods tested body image as a mediator between bowel and GI symptom
severity and two indicators of psychological distress (depressive and anxiety symptoms),
controlling for relevant covariates. Measures included the EORTC-QLQ-CR38 Diarrhea, GI
Symptoms, and Body Image subscales and Brief Symptom Index Depression and Anxiety
subscales.
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Conclusions—Long-term bowel and GI dysfunction are distressing and affect how women
perceive and relate to their bodies, exacerbating survivorship difficulties. Interventions to improve
adjustment post-treatment should address treatment side effects, but also target body image
problems to alleviate depressive symptoms. Reducing anxiety may require other strategies. Body

Results—Women averaged 55 years old (SD=11.6), White (79%), and 4-years post-treatment.
Greater Depression related to poorer body image (r=−.61) and worse diarrhea (r=.35) and GI
symptoms (r=.48). Greater Anxiety related to poorer body image (r=−.42) and worse GI symptoms
(r=.45), but not diarrhea (r=.20). Body image mediated the effects of bowel and GI symptoms on
Depression, but not on Anxiety.
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image may be a key modifiable factor to improve well-being in this understudied population.
Longitudinal research is needed to confirm findings.
Keywords
rectal cancer; anal cancer; psychological distress; body image; bowel dysfunction; gastrointestinal
symptoms
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Treatment for rectal and anal cancer often includes radiation, chemotherapy, and surgery,
alone or in combination, and may include a temporary or permanent stoma. These treatments
often result in adverse side effects including bowel and gastrointestinal (GI) dysfunction that
can last for years post-treatment [1, 2]. Negative psychological reactions to unpleasant
changes in body functioning and appearance may exacerbate these difficulties [3]. Given the
prevalence and persistence of bowel and GI dysfunction post-treatment and quality of life
implications, identifying modifiable factors that alleviate distress is an important
survivorship concern.
Following treatment for rectal and anal cancer, prevalence estimates for bowel and GI
dysfunction range from 13–49% for diarrhea and 7–16% for GI symptoms [add refs 4–7] [8,
9], which may persist for years into survivorship [10, 11]. Survivors coping with bowel and
GI symptoms report disruptions in daily routines and social activities, sexual dysfunction,
and reduced emotion well being and quality of life [5, 12–14]. Although research in rectal
and anal cancer is limited, greater severity of bowel and GI symptoms increases the
likelihood of anxiety and depression in colorectal patients [15, 16]. Medical interventions
typically include medication and diet alterations and have mixed results. Identifying
modifiable factors that exacerbate symptom-related distress is warranted.
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Given unpleasant, disruptive, and potentially distressing side effects, problems with body
image may develop. Problems with body image may refer to dissatisfaction with body
functioning or appearance and can have a profound affect on identity and self-concept,
particularly for women [17, 18] Both rectal and anal cancer survivors report significant body
image concerns [2, 19–21]. Bowel and GI dysfunction appear to be related to reported body
image difficulties [22][23]. The ways in which survivors view and accept their bodies while
experiencing unwanted body changes may be one mechanism by which treatment side
effects influence psychological well-being in survivorship. For women, in particular,
changes in body image may have more generalized effects on psychosocial well-being [3].
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The available literature on rectal and anal cancer survivorship has primarily used descriptive
statistics to characterize quality of life domains and the co-occurrence of treatment side
effects. There has been little evaluation of how treatment side effects may relate to body
image problems and potential implications for more general measures of psychological
distress. Among colorectal cancer survivors, disturbances in body image have been
associated with higher levels of post-treatment distress, depression, and anxiety [24, 26, 27].
Prospective studies in other cancers corroborate these relations indicating that body image
may precede psychosocial difficulties [3]. The unique experiences of rectal and anal cancer
survivors are not well understood, however, and little is known about what factors may lead
to greater psychological distress for this specific group.
Support Care Cancer. Author manuscript; available in PMC 2017 April 01.
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Present Study
This study aimed to evaluate the degree to which bowel and GI dysfunction related to
psychological distress in women who completed treatment for rectal or anal cancer. We also
examined whether body image mediated the effect of bowel and GI dysfunction on
psychological distress. Specifically, we tested whether relations varied based on using
depressive versus anxiety symptoms as indicators of psychological distress. We
hypothesized that poorer body image, as a result of persistent bowel and GI symptoms,
would be related to increased depressive and anxiety symptoms. Determining which aspects
of psychological distress may be alleviated by targeting body image problems can be used to
inform the development of intervention techniques to improve coping and quality of life in
post-treatment survivorship.
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Methods
Participants
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Participants (N=70) were part of a sexual health intervention study for women reporting low
to moderate satisfaction with their sexual functioning and overall sexual life (see Philip and
colleagues [28] for full study information). Sexual satisfaction was assessed using an item
from the Female Sexual Function Index (“Over the past 4 weeks, how satisfied have you
been with your overall sexual life?”; 5=Very Satisfied to 1=Very Dissatisfied) and
individuals scoring a 5 were excluded [29]. Inclusion criteria included being post-treatment
(post-radiation and/or surgery for stage I-III rectal adenocarcinoma or rectosigmoid cancer
with an anastomosis at 15 cm or below; post-radiation and/or chemotherapy for anal cancer)
with no evidence of disease, at least 21 years old, and proficient in English. Informed
consent was obtained from all participants. All study materials and procedures were
approved by the Institutional Review Board. Data from the baseline assessment (preintervention) was used.
Measures
Socio-Demographic and Medical Information—Socio-demographic information was
collected using standard questionnaires. Medical and treatment data were collected via
medical chart review.
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Bowel and Gastrointestinal Symptoms and Body Image—The European
Organization for Research and Treatment of Cancer (EORTC) Core Quality of Life
Questionnaire (QLQ-C30)[30] and Colorectal Cancer-Specific Module (QLQ-CR38)
assessed bowel and GI symptoms and body image.[7] The QLQ-C30 (30-items) is a well
validated self-report measure of health-related quality of life in cancer patients. The QLQCR38 is a supplement that includes 38 additional items specific to colorectal cancer. Bowel
and GI symptoms were measured using the Diarrhea single item (“Have you had diarrhea?”)
and the five-item GI Symptoms subscale (e.g., feeling bloated, gas, and pain in abdomen).
Body Image was measured with three items that assess whether respondents feel physically
less attractive, less feminine, and/or dissatisfied with their bodies as a result of cancer
treatment. All items are rated on a four-point Likert scale (“Not at All” to “Very Much”).
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Scores range from 0–100 with higher scores indicating greater severity of symptoms and
better body image.
Psychological Distress—Depressive and anxiety symptoms were selected as two indices
of psychological distress and measured by the Brief Symptom Inventory (BSI)[31]
Depression and Anxiety subscales, respectively. Each subscale includes six items that ask
respondents to rate how much discomfort problems have caused them in the past month on a
five-point Likert scale (“Not at all” to “Extremely”). Individual scores for the items on each
subscale were averaged. Scores range from 0 to 3, with higher scores indicating higher levels
of depressive and anxiety symptoms. Both the Depression and Anxiety subscales
demonstrated good internal consistency reliability in this sample (Cronbach’s alphas, .77
and .87, respectively).
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Statistical Analysis
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Descriptive statistics and Pearson correlations were performed for all study variables.
Independent sample t-tests examined differences between women with and without a stoma.
The role of body image mediating the effect of bowel and GI symptoms on psychological
distress was tested with four models that specified Diarrhea and GI Symptoms as predictors,
Body Image as a mediator, and Depression and Anxiety as outcome variables (Figure 1).
Each model provided estimates and confidence intervals around the indirect (mediating)
effects of the predictors on the outcomes through the mediator. Traditional tests of mediation
require assumptions of normality that may be violated with smaller samples. Therefore,
bootstrap methods were used to obtain nonparametric estimates of sampling distributions of
the indirect effects [32], which maximizes statistical power [33]. The indirect effect was
regarded significant if a zero was not included in the confidence interval of the estimate,
indicating that Body Image mediated the relation between the predictor and the outcome.
Bootstrap analysis was conducted in SPSS v. 22 with Hayes (2012) PROCESS Macro [34].
Based on standard recommendations, the bootstrapped mediated effects (BMED) and 95%
bias-corrected and accelerated (BCa) confidence intervals for indirect effects were obtained
from 5,000 bootstrapped samples [32].

Results
Tables 1 and 2 present descriptive data. Participants were a convenience sample of mostly
rectal cancer survivors (71%), averaged 4.3 years (SD=3.3, median=4) post-treatments, and
had undergone multimodal treatments (73% had surgery; 71% underwent radiation/
chemotherapy combined). Ten participants (14%) had a permanent stoma.
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Thirty-seven percent of women reported diarrhea in the past week; 34% reported feeling
bloated, 35% had abdominal pain, 23% reported pain in their buttocks, 73% were bothered
by gas, and 46% reported belching. Sixty-one percent of women were dissatisfied with their
body and 49% reported two or more body image problems. Average levels of depressive and
anxiety symptoms were higher than non-patient normative levels for women [31]. Based on
a validated case rule to determine “psychological distress,” 16% and 21% of participants
reported clinically significant levels of depressive and anxiety symptoms, respectively
(above the 90th percentile, T score ≥ 63) [31].
Support Care Cancer. Author manuscript; available in PMC 2017 April 01.
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Survivors with a stoma reported more anxiety symptoms than survivors without a stoma
(M=1.02 and 0.58, respectively; t[68]=−2.16, p=.03). No other sociodemographic variables
were related to Depression or Anxiety in bivariate analysis (p’s >.10) Younger age was
associated with poorer Body Image (r=.29, p=.02). Stoma patients reported poorer Body
Image than non-stoma status at the trend level (t[67]= 1.71, p=.09). Table 3 presents
bivariate correlations of the main variables.
Mediation Analyses
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Based on a priori hypotheses, four mediation models were tested (Figure 1). Direct effects
evaluated relations between predictors and the mediator (path a), the mediator and the
outcomes (path b), and the predictors and the outcomes (path c). As a test of mediation,
indirect effects estimated the degree to which Diarrhea or GI Symptoms related to
Depression or Anxiety while accounting for the mediated effect of Body Image (path c’). All
models included age and presence of a permanent stoma (yes/no) as covariates (selected a
priori) [3, 26].Sexual satisfaction was controlled for methodologically as an eligibility
criterion with all participants reporting moderate to low satisfaction. To ensure that
variability in participants’ overall sexual function was adequately controlled for, analyses
were also conducted with a multidimensional measure of sexual function included as an
additional covariate [29]. Given no significant difference in results, sexual function was not
included in the final models. Results are summarized in Table 4.
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Predicting Depressive Symptoms—The first mediation model tested the indirect effect
of Diarrhea on Depression through Body Image. The paths from Diarrhea to Body Image
(b=−.432, p<.001), from Body Image to Depression (b=−.014, p<.001), and the unmediated
path, or the total effect, from Diarrhea to Depression (b=.007, p=.009) were significant. The
inclusion of Body Image in the model indicated a significant indirect effect from Diarrhea to
Depression through Body Image (bootstrapped mediated effect, BMED=0.006, 95% BCa CI
[0.002–0.012]) with the direct effect of Diarrhea on Depression no longer significant (b=.
001, p=.59), supporting mediation. Each one unit increase in reported Diarrhea resulted in a .
006 increase in the predicted value of Depression through Body Image. More specifically, an
increase of one standard deviation in Diarrhea (SD=29.82) was predictive of a 0.177 unit
increase in Depression.
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The second mediation model tested the indirect effect of GI Symptoms on Depression
through Body Image. The paths from GI Symptoms to Body Image (b=−.754, p< .001),
from Body Image to Depression (b=−.012, p<.001), and total effect from GI Symptoms to
Depression (b=.016, p<.001) were significant. When Body Image was included in the
model, the indirect effect was significant (BMED=0.009, 95% BCa CI [0.003 – 0.018]),
though the direct effect of GI Symptoms on Depression also remained significant (b=.008,
p=.048), suggesting Body Image was a partial mediator. An increase of one standard
deviation in reported GI Symptoms (SD=20.06) was predictive of a 0.181 unit increase in
Depression.
Predicting Anxiety Symptoms—To test the mediating role of Body Image between
Diarrhea and Anxiety, Diarrhea was specified as the predictor, Body Image as the mediator,
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and Anxiety as the outcome. The paths from Diarrhea to Body Image (b=−.432, p<.001) and
from Body Image to Anxiety (b=−.008, p=.002) were significant. However, the unmediated
path (total effect; b=.003, p=.29) and the direct effect (b=−.001, p=.72) of Diarrhea on
Anxiety were not significant. The indirect effect of Diarrhea on Anxiety via Body Image
was significant (BMED=0.003, 95% BCa CI [0.001 – 0.007]), suggesting inconsistent
mediation [35]. The mediating role of Body Image in this model should be interpreted with
caution as the direct and total effects of Diarrhea on Anxiety were small and not statistically
different from zero.
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The final mediation model tested the indirect effect of GI Symptoms on Anxiety through
Body Image. The paths from GI Symptoms to Body Image (b=−.754, p<.001) and from GI
Symptoms to Anxiety (b=.013, p<.001) were significant. However, the path from Body
Image to Anxiety (b=−.004, p=.15) was not significant. When Body Image was included in
the model, the indirect effect of GI Symptoms on Anxiety via Body Image was not
significantly different from zero (BMED=0.003, 95% BCa CI [-0.001 – 0.008]) and the
direct effect of GI Symptoms to Anxiety remained significant (b=.010, p=.007). Findings
support a direct effect of GI Symptoms on Anxiety, but mediation between GI Symptoms
and Anxiety via Body Image was not supported.

Discussion
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Among women who averaged four years post-treatment for rectal and anal cancer, greater
severity of diarrhea and GI symptoms directly related to poorer body image and greater
depressive and anxiety symptoms. Poorer body image emerged as a significant mediator of
the negative effects of diarrhea and GI dysfunction on depressive symptoms. Contrary to
expectations, body image did not mediate the effect of diarrhea and GI symptoms on
anxiety.

Author Manuscript

Persistent, unwanted changes in body functioning as a result of cancer treatments can
profoundly affect the ways in which survivors view themselves and interact with the world.
Bowel dysfunction, for example, is associated with social stigma and patients’ difficulty
managing irregularity and unpredictability and fear of incontinence often leads to
disruptions in social functioning.[23] Poorly managed bowel and GI symptoms lead to
reduced quality of life and lowered self-confidence.[36, 12] Women may feel embarrassed or
self-conscious, particularly in the context of dating and romantic relationships, or during
sexual activity.[37] Forty-seven percent of women in our sample reported feeling less
feminine as a result of their disease and treatment and 40% reported feeling less attractive.
The development of body image problems may exacerbate these difficulties and lead to
increased risk of depression. Importantly, body image represents an inherently subjective
construct and may persist even if side effects subside.[2, 19, 21]
Associations were weaker with the anxiety symptoms subscale, and mediation was not fully
supported. In bivariate analyses, GI symptoms, but not diarrhea, related to anxiety. In noncancer populations, both diarrhea and GI symptoms are associated with increased anxiety
[38], and it is unknown why diarrhea was unrelated to anxiety in our sample. Items used to
measure anxiety in these analyses did not include GI symptoms, but did measure physical

Support Care Cancer. Author manuscript; available in PMC 2017 April 01.

Benedict et al.

Page 7

Author Manuscript

sensations of feeling “tense or keyed up” and “nervousness or shakiness inside.” In the test
of mediation, this overlap may have precluded relations with body image to emerge.
This study provides some insight into the ways in which body image problems may
exacerbate other difficulties associated with treatment effects. Findings are partially
consistent with the literature [3]. After colorectal cancer treatment, Bullen et al. [26]
demonstrated that in the three month post-operative time period, poor body image predicted
worsening depression and anxiety over time. Sharpe et al. [24] reported cross-sectional
relations between body image and depression and anxiety in colorectal patients immediately
following surgery, though longitudinal relations were only significant for anxiety, not
depression. Both studies included a greater proportion of stoma patients than we had in our
sample, which was found to increase the risk of deteriorating body image over time [24, 26].
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Further investigation of differential predictors of depressive vs. anxiety symptoms in longterm rectal and anal cancer survivorship is warranted. Findings suggest depressive symptoms
may directly improve as body image concerns are addressed, even in the presence of
diarrhea and GI symptoms and controlling for the effects of age and stoma status. Given that
body image and anxiety symptoms were related in bivariate analyses and based on the
literature, further investigation into the potential utility of addressing body image problems
to alleviate anxiety may be insightful. Alternatively, anxiety symptoms may have other,
more significant predictors and there may be better targets of intervention to address this
aspect of psychological distress.
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While predictive relations cannot be assumed, longitudinal studies suggest that targeting
body image problems lead to improvements in more general indicators of psychosocial well
being in colorectal [24, 26], breast [43, 44], and head and neck cancer survivorship [45].
Hopwood and Maguire [18] argue that for cancer survivors who experience change in body
function, disturbances in body image are one of the primary mechanisms that explain
observed increases in psychological morbidity. This is supported by theory that delineates
body image as a precursor to more global psychosocial difficulties among cancer survivors.
For example, cognitive behavioral models identify “body image schemas,” which when
threatened by perceived or actual changes in body functioning or appearance, influence
cognitive processing, emotional experiences, and compensatory behaviors [17].
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Based on this literature, a baseline, pre-treatment assessment of patients’ body perceptions
and expectations for post-treatment recovery could help identity patients at risk for posttreatment difficulties and streamline the delivery of supportive services. Likewise, periodic
assessment of body image concerns in survivorship care may help identify the development
of body image problems. Psychosocial interventions should be offered to women who have
difficulty adjusting to and coping with persistent treatment-related side effects.
Prevailing evidence supports the use of time-limited, cognitive behavioral therapy to address
issues related to body image after cancer treatment, though other techniques have also
shown promise (e.g., educational and physical fitness interventions) [3]. In addition to
learning problem solving strategies to manage symptoms, addressing maladaptive body
schemas and promoting acceptance of changes in body functioning and/or appearance may
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be critical. Women may also benefit from learning communication strategies to navigate
uncomfortable situations in which bowel and GI symptoms could interfere with social or
sexual encounters. Women may harbor cognitive distortions regarding their partners’ (or
future partners’) reaction to body changes. Addressing their fears of rejection or
embarrassment may be important. Further work is needed to empirically test whether
improvements in body image lead to improved psychological distress in this patient
population.
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The present study has several limitations. Although analyses were based on theoretical
models of body image in cancer populations, cross-sectional analyses preclude causal
inferences. The relatively small sample size and primary focus of the study prevented the
inclusion of additional, potentially important covariates (e.g., premorbid mood disorders,
history of psychopathology). We were also unable to consider other potentially important
aspects of post-treatment recovery. For example, although sexual satisfaction was controlled
for methodologically, post-treatment sexual dysfunction has been shown to directly relate to
body image disturbances and the complex interaction of these constructs should be evaluated
further [27]. The sample was made up of women who agreed to participate in a sexual health
intervention study and reported moderate to low sexual satisfaction. Participants’ sexual
dissatisfaction, as well as their willingness to participate in a sexual intervention, may
indicate important distinctions from other survivors. Although this may represent an
important subgroup that may be vulnerable to body image difficulties, our findings may not
generalize to broader populations of rectal and anal cancer survivors.
Conclusions
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A wealth of literature has explored factors associated with heightened psychological distress
and poor quality of life in cancer survivorship. Many of these are immutable (e.g., age,
disease stage, cancer treatment). In contrast, body image may be a more modifiable risk
factor that can be targeted by psychosocial interventions. These preliminary findings suggest
that body image concerns may be associated with increased psychological distress resulting
from persistent side effects following rectal and anal cancer treatment. Further work is
needed to understand how trajectories of body image interact with the development of
depressive and anxiety symptoms over time. Interventions to improve adjustment and quality
of life should address treatment side effects, but also target body image concerns to alleviate
depressive symptoms.
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Figure 1.

Four mediation models were tested including bowel and GI symptoms as predictors,
depressive and anxiety symptoms as outcomes, and body image as a mediator. DEP =
depressive symptoms; ANX = anxiety symptoms; a = direct effect of bowel or GI symptoms
on body image; b = direct effect of body image on depressive or anxiety symptoms; c =
unmediated path from bowel or GI symptoms to depressive or anxiety symptoms (total
effect); c’ = direct effect from bowel or GI symptoms to depressive or anxiety symptoms
accounting for the mediated effect of body image.
*Tested in separate models.
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Author Manuscript

Sample Characteristics (N = 70)
M

SD

Age (years)

55.4

11.6

Time since treatment (years)

4.3

3.3

n

%

Hispanic

5

8

Not Hispanic

56

92

American Indian/Alaska Native

1

1

Asian

3

1

Black or African American

6

59

White

55

33

Other

2

2

Single

11

16

Married

40

57

Demographic Information

Ethnicity

Race

Author Manuscript

Marital Status

Separated

3

4

Divorced

11

16

Widowed

5

7

Unemployed

11

16

Homemaker

6

9

Employed, Full- or Part-time

33

49

Retired

14

21

Other

4

6

Less than High School

2

33

High School Degree

5

8

Some College

15

24

College Degree

16

26

Some Graduate School

24

39

Less than $50,000

17

31

More than $50,000

38

69

11

16

Employment Status

Author Manuscript

Education Level

Income Status

Author Manuscript

Type of Health Insurance
MediCARE
MedicAID

2

3

Private/Commercial

43

61

No insurance/Self-pay

1

1
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Demographic Information

M

SD

Medical Information

n

%

Rectal cancer

48

69

Anal cancer

20

29

1

22

31

2

10

14

3

29

41

Cancer Type

Presurgical Stage

Treatment Neoadjuvant/Adjuvant

Author Manuscript

Radiation only

1

1

Chemotherapy only

8

11

Radiation/Chemotherapy

50

71

Surgical treatment

51

73

Permanent stoma

10

14

Treatment Side Effects1

n

%

Diarrhea

26

37

Feeling bloated

24

34

Abdominal pain

25

35

Pain in buttocks

16

23

Bothered by gas

51

73

Belching

32

46

Surgery

1

Author Manuscript

Measured using the QLQ-C30 and QLQ-C38; refers to participants who reported experiencing symptoms “A little,” “Quite a bit,” or “Very much”
in the past week.
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Table 2

Author Manuscript

Descriptive Statistics for Study Variables
Mean (SD)

N

Diarrhea

20.29 (29.82)

69

Gastrointestinal Tract Symptoms

21.45 (20.06)

69

Body Image

69.24 (30.85)

69

Depression

0.59 (0.69)

70

Anxiety

0.65 (0.60)

70

Note: Higher numbers indicate greater sexual satisfaction, greater severity of symptoms, better body image, and more depression/anxiety.
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Author Manuscript
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Author Manuscript
.015
−.204†

−.001
.289*
−.154
−.123

5. Body Image

6. Depressive Symptoms

7. Anxiety Symptoms

.195

.253*

−.421**

−.609**

–

5

.646**

–

6

p < .01

p < .05;

**

*

p < .10;

†

Note: Stoma status was dichotomized for ease of interpretation: 0=not present; 1=present.

.445**

.481**

.346**

.055

–
−.494**

.360**

–

3

−.437**

.135

−.032

4. GI Symptoms

–

3. Diarrhea

–
.077

2. Stoma Status

1. Age

2

4

Author Manuscript
1

–

7

Author Manuscript

Pearson Correlations for all Study Variables

Author Manuscript
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Author Manuscript

Author Manuscript
−.004

−.754***

GI Symptoms

.013***

.003

.016***

.007*

c

.010**

−.001

.008*

.001

c’

.003

.003

.009

.006

BMED

.0022

.0017

.004

.002

SE

−.001

.001

.003

.002

95%
BCa LL

.008

.007

.018

.012

95%
BCa UL

p < .001.

***

p < .01;

**

p < .05;

Percentile based 95% confident intervals are presented for this model.

*

§

Note. The bootstrapped effect was based on 5,000 bootstrap samples. Analyses were adjusted for age and stoma status. a = path from predictor (diarrhea or GI symptoms) to body image; b = path from body
image to outcome (depression or anxiety); c = unmediated path from predictor to outcome (total effect); c’ = direct effect from predictor to outcome after accounting for the mediated effect; BMED =
bootstrapped mediated effect (indirect effect); SE = standard error of the bootstrapped mediated effect; BCa = bias-corrected and accelerated bootstrap confidence interval; LL = lower limit; UL = upper
limit.

−.008**

−.012***

−.014***

b

−.432**

−.754***

−.432**

a

Diarrhea§

Anxiety

GI Symptoms

Diarrhea

Depression

Mediation Models

Unstandardized Path Coefficients and Bootstrap Mediated Effects with Confidence Intervals for All Models

Author Manuscript
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